Related Experiment Video
Updated: May 31, 2026
08:49
Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes
Published on: March 14, 2021
Ceramide transfer protein and cancer.
Luana Scheffer1, Pralhada Rao Raghavendra, Jingjing Ma
1Laboratory of Cell and Developmental Signaling, National Cancer Institute Frederick, MD 21702, USA.
Anti-Cancer Agents in Medicinal Chemistry
|June 29, 2011
Summary
Sphingolipids, crucial for cell membranes and signaling, are key in cancer research. This review highlights ceramide transfer protein (CERT) and its role in regulating ceramide flux, impacting tumor cell death.
Area of Science:
- Biochemistry
- Cell Biology
- Cancer Research
Background:
- Sphingolipids are vital membrane components and cellular signaling molecules.
- Ceramide is central to sphingolipid metabolism and influences tumor cell death.
- Altered ceramide levels affect cancer cell sensitivity to stress.
Purpose of the Study:
- To review the role of ceramide transfer protein (CERT) in regulating cellular ceramide flux.
- To explore the significance of CERT in the context of cancer research and cell death pathways.
Main Methods:
- Literature review focusing on sphingolipid metabolism and cancer.
- Analysis of studies investigating ceramide transfer protein (CERT) function.
- Synthesis of current understanding of ceramide flux regulation.
Main Results:
- Ceramide transfer protein (CERT) is identified as a key regulator of ceramide transport within cells.
- CERT activity influences the cellular ceramide pool, impacting cell survival and death.
- Understanding CERT's role provides insights into novel cancer therapeutic strategies.
Conclusions:
- Ceramide transfer protein (CERT) plays a critical role in managing ceramide levels and signaling.
- Targeting CERT may offer a new approach to modulating tumor cell death and enhancing cancer therapy.
- Further research into CERT function is warranted for its translational potential in oncology.
Related Concept Videos
01:35Cancer Cell Migration through Invadopodia
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:27Post-translational Translocation of Proteins to the RER
A sizable fraction of proteins destined for ER are first synthesized in the cell cytosol and then transported across the ER membrane–a process called post-translational translocation. Similar to cotranslationally translocated proteins, these proteins also use the Sec translocon complex to enter the ER lumen.
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
01:06Carrier-Mediated Transport
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...